• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting the complicated neutropenic fever in the emergency department.预测急诊科复杂中性粒细胞减少性发热。
Emerg Med J. 2009 Nov;26(11):802-6. doi: 10.1136/emj.2008.064865.
2
Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.泰国中性粒细胞减少伴发热患者并发症及预后预测风险指数
J Med Assoc Thai. 2003 Mar;86(3):212-23.
3
Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.与急诊化疗引起的发热性中性粒细胞减少症患者并发症相关的风险因素。
Hematol Oncol. 2013 Dec;31(4):189-96. doi: 10.1002/hon.2040. Epub 2013 Jan 9.
4
Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.对因治疗导致中性粒细胞减少性发热的妇科肿瘤患者进行回顾性研究。
Gynecol Oncol. 1996 Aug;62(2):247-53. doi: 10.1006/gyno.1996.0223.
5
The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.C反应蛋白、白细胞介素-8和单核细胞趋化蛋白在血液系统恶性肿瘤发热性中性粒细胞减少儿童风险分层中的诊断价值。
J Pediatr Hematol Oncol. 2007 Mar;29(3):131-6. doi: 10.1097/MPH.0b013e3180308770.
6
Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.预测发热伴化疗所致中性粒细胞减少症儿童的不良事件:前瞻性多中心 SPOG 2003 FN 研究。
J Clin Oncol. 2010 Apr 20;28(12):2008-14. doi: 10.1200/JCO.2009.25.8988. Epub 2010 Mar 15.
7
Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.癌症患者化疗引起的发热性中性粒细胞减少症预后不良的预测因素。
Support Care Cancer. 2011 Aug;19(8):1151-8. doi: 10.1007/s00520-010-0928-4. Epub 2010 Jun 16.
8
Independent factors for prediction of poor outcomes in patients with febrile neutropenia.发热性中性粒细胞减少症患者不良预后的预测因素
Med Sci Monit. 2014 Oct 5;20:1826-32. doi: 10.12659/MSM.892269.
9
Management of febrile neutropenia in an acute oncology service.急性肿瘤科室中性粒细胞减少伴发热的管理
QJM. 2012 Apr;105(4):327-36. doi: 10.1093/qjmed/hcr217. Epub 2011 Nov 12.
10
Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever.在从中性粒细胞减少性发热中恢复的癌症患儿中,如血清C反应蛋白所示,中性粒细胞再生先于组织破坏的愈合。
Acta Paediatr. 2002;91(8):915-9. doi: 10.1080/080352502760148630.

引用本文的文献

1
Plasma Profiling of Acute Myeloid Leukemia With Fever- and Infection-Related Complications During Chemotherapy-Induced Neutropenia.化疗诱导中性粒细胞减少期间伴发热和感染相关并发症的急性髓系白血病的血浆特征分析。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70024. doi: 10.1002/cnr2.70024.
2
Acute Oncologic Complications: Clinical-Therapeutic Management in Critical Care and Emergency Departments.急性肿瘤并发症:重症监护和急诊科的临床治疗管理。
Curr Oncol. 2023 Aug 2;30(8):7315-7334. doi: 10.3390/curroncol30080531.
3
Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer.一项评估 PF-06881894 单剂递增和多剂皮下给药在非远处转移性乳腺癌女性中的临床药理学和安全性的 I/II 期研究。
Cancer Chemother Pharmacol. 2021 Dec;88(6):1033-1048. doi: 10.1007/s00280-021-04355-6. Epub 2021 Oct 7.
4
Machine Learning for Early Warning of Septic Shock in Children With Hematological Malignancies Accompanied by Fever or Neutropenia: A Single Center Retrospective Study.机器学习用于伴有发热或中性粒细胞减少的血液系统恶性肿瘤儿童脓毒性休克的早期预警:一项单中心回顾性研究
Front Oncol. 2021 Jun 15;11:678743. doi: 10.3389/fonc.2021.678743. eCollection 2021.
5
Diagnosis and Management of Oncologic Emergencies.肿瘤急症的诊断与处理。
West J Emerg Med. 2019 Mar;20(2):316-322. doi: 10.5811/westjem.2018.12.37335. Epub 2019 Feb 14.
6
Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA.急诊科癌症发热性中性粒细胞减少症患者预后不良的预测因素:qSOFA的应用价值
J Oncol. 2018 Oct 11;2018:2183179. doi: 10.1155/2018/2183179. eCollection 2018.
7
Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.降钙素原、可溶性髓系细胞触发受体-1和C反应蛋白在血液系统恶性肿瘤患者中的诊断效能
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22147. Epub 2017 Jan 30.
8
Independent factors for prediction of poor outcomes in patients with febrile neutropenia.发热性中性粒细胞减少症患者不良预后的预测因素
Med Sci Monit. 2014 Oct 5;20:1826-32. doi: 10.12659/MSM.892269.
9
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients.疑似稳定的成年癌症患者中性粒细胞减少性发热的预后评估。
Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284. Epub 2011 Aug 2.
10
C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia.严重癌症合并脓毒症患者的 C 反应蛋白:中性粒细胞减少的影响。
Crit Care. 2011;15(3):R129. doi: 10.1186/cc10242. Epub 2011 May 19.

本文引用的文献

1
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.口服莫西沙星或静脉注射头孢曲松用于治疗适合早期出院的癌症患者低风险中性粒细胞减少性发热。
Support Care Cancer. 2008 Sep;16(9):1017-23. doi: 10.1007/s00520-007-0383-z. Epub 2008 Jan 15.
2
Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.发热性中性粒细胞减少症癌症患者预后的预测:癌症支持治疗多国协会风险指数评分与降钙素原、C反应蛋白、血清淀粉样蛋白A以及白细胞介素-1β、-6、-8和-10的比较
Eur J Cancer Care (Engl). 2007 Nov;16(6):475-83. doi: 10.1111/j.1365-2354.2007.00780.x.
3
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.低风险发热性中性粒细胞减少症癌症患者每日一次口服喹诺酮单药门诊治疗:基于经验证的风险预测规则对40例患者的初步研究
Cancer. 2006 Jun 1;106(11):2489-94. doi: 10.1002/cncr.21908.
4
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.评估全身炎症标志物以区分发热性中性粒细胞减少症患者的临床病程是稳定还是恶化。
Eur J Haematol. 2005 Apr;74(4):297-303. doi: 10.1111/j.1600-0609.2004.00387.x.
5
Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.21世纪癌症发热性中性粒细胞减少患者的管理前景
Cancer. 2005 Mar 15;103(6):1103-13. doi: 10.1002/cncr.20890.
6
The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.降钙素原和C反应蛋白对发热性中性粒细胞减少症患者临床结局的预测和诊断价值。
J Chin Med Assoc. 2004 May;67(5):217-21.
7
Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.使用炎症标志物早期检测发热性中性粒细胞减少症患者的菌血症
Scand J Infect Dis. 2004;36(5):365-71. doi: 10.1080/00365540410020217.
8
Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.发生发热伴肺部浸润的血液系统恶性肿瘤患者的风险评估:一项历史性队列研究。
Cancer. 2004 Aug 1;101(3):567-77. doi: 10.1002/cncr.20406.
9
Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.评估降钙素原作为实体瘤合并发热性中性粒细胞减少症患者的诊断和预后标志物。
Cancer. 2004 Jun 1;100(11):2462-9. doi: 10.1002/cncr.20275.
10
Pneumonia in neutropenic patients.中性粒细胞减少患者的肺炎
Eur Radiol. 2004 Feb;14(2):256-71. doi: 10.1007/s00330-003-1985-6. Epub 2003 Jul 24.

预测急诊科复杂中性粒细胞减少性发热。

Predicting the complicated neutropenic fever in the emergency department.

机构信息

Department of Emergency Medicine, Chonnam National University Hospital, Gwangju, South Korea.

出版信息

Emerg Med J. 2009 Nov;26(11):802-6. doi: 10.1136/emj.2008.064865.

DOI:10.1136/emj.2008.064865
PMID:19850806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2773519/
Abstract

OBJECTIVES

The purpose of this study was to identify independent factors that can be used to predict whether febrile neutropenic patients who appear healthy at presentation will develop subsequent complications, using variables that are readily available in the emergency department (ED).

METHOD

The medical records of 192 episodes in which the patients presented to the ED with neutropenic fever resulting from chemotherapy, with an alert mental state and haemodynamic stability were retrospectively reviewed. Endpoints examined were fever response to administered antibiotics, death or severe medical complications during hospitalisation.

RESULTS

Thirty-eight episodes of neutropenic fever with complicated outcomes were identified from among a total of 192 episodes. Three parameters emerged as independent factors for the prediction of neutropenic fever with complications in the multivariate regression analysis: platelet count (130-450 x 10(3) cells/mm(3)) <50 000 cells/mm(3), serum C-reactive protein (CRP, 0.1-1 mg/dl) >10 mg/dl and pulmonary infiltration on chest x ray.

CONCLUSIONS

Platelet count, CRP and pulmonary infiltration on chest x ray at presentation could be used to identify febrile neutropenic patients who will develop complications, and these factors may be useful in making treatment-related decisions in the ED.

摘要

目的

本研究旨在确定可用于预测表现健康的发热性中性粒细胞减少症患者是否会发生后续并发症的独立因素,所使用的变量在急诊科(ED)中易于获得。

方法

回顾性分析了 192 例因化疗引起中性粒细胞减少性发热并伴有警觉性精神状态和血流动力学稳定的患者在急诊科就诊的病历。检查的终点是给予抗生素后的发热反应、住院期间死亡或严重医疗并发症。

结果

在总共 192 例发热性中性粒细胞减少症中,有 38 例出现复杂的中性粒细胞减少性发热并发症。多变量回归分析中,有三个参数是中性粒细胞减少性发热合并并发症的独立预测因素:血小板计数(130-450 x 10(3) 细胞/mm(3))<50 000 细胞/mm(3)、血清 C 反应蛋白(CRP,0.1-1 mg/dl)>10 mg/dl 和胸部 X 线片有肺部浸润。

结论

在发热性中性粒细胞减少症患者就诊时的血小板计数、CRP 和胸部 X 线片上的肺部浸润可用于识别可能发生并发症的患者,这些因素可能有助于在急诊科做出与治疗相关的决策。